Role of QuantiFERON-TB Gold Antigen-specific IL-1β in Diagnosis of Active Tuberculosis
Overview
Affiliations
The main objective of the study was to evaluate whether in vitro QuantiFERON-TB Gold In-Tube (QFT-GIT) assay antigen-specific IL-1β, TNF-α, IL-2, IL-6, IL-8 and IL-12 (p40) production is associated with active TB. In a cohort of 77 pulmonary TB patients (PTB), 67 healthy household contacts (HHC) and 83 healthy control subjects (HCS), the antigen-specific cytokines levels were determined in supernatants generated from QFT-GIT tubes. Antigen-specific IL-1β levels were significantly higher in PTB than HHC and HCS. At a fixed cutoff point (1,108 pg/ml), IL-1β showed positivity of 62.33% in PTB, 22.38% in HHC and 22.89% in HCS. Moreover, antigen-specific IL-1β assay can differentiate PTB and HHC (believed to be latently infected) (p < 0.0001). Like IL-1β, significantly higher levels of antigen-specific TNF-α were associated with PTB and displayed 43.63% positivity in PTB. The antigen-specific IL-2 levels were associated both with PTB (54.54%) and HHC (48.14%). Other cytokines levels did not differ among the groups. Our results suggest that antigen-specific IL-1β can be used as a biomarker for active TB diagnosis as well as for differential diagnosis of PTB and LTBI.
Dinh P, Tran C, Dinh T, Ha H, Utegenova A, Ali A Biochem Biophys Rep. 2025; 41:101952.
PMID: 40034257 PMC: 11875834. DOI: 10.1016/j.bbrep.2025.101952.
Chauhan A, Parmar M, Dash G, Solanki H, Chauhan S, Sahoo K Indian J Community Med. 2024; 49(5):669-680.
PMID: 39421504 PMC: 11482387. DOI: 10.4103/ijcm.ijcm_36_24.
The prevalence of tuberculosis infection in India: A systematic review and meta-analysis.
Chauhan A, Parmar M, Dash G, Solanki H, Chauhan S, Sharma J Indian J Med Res. 2023; 157(2&3):135-151.
PMID: 37202933 PMC: 10319385. DOI: 10.4103/ijmr.ijmr_382_23.
Lee M, Chang L, Chang C, Yan B, Wang J, Lin W Dis Markers. 2019; 2019:7869576.
PMID: 31781307 PMC: 6875314. DOI: 10.1155/2019/7869576.
Kisuya J, Chemtai A, Raballah E, Okumu W, Keter A, Ouma C Pan Afr Med J. 2019; 31:166.
PMID: 31086619 PMC: 6488244. DOI: 10.11604/pamj.2018.31.166.17294.